GlaxoSmithKline
GSK
#209
Rank
HK$760.42 B
Marketcap
HK$376.72
Share price
-0.33%
Change (1 day)
44.94%
Change (1 year)

GlaxoSmithKline (GSK) - Total assets

Total assets on the balance sheet as of September 2025 : HK$641.68 Billion

According to GlaxoSmithKline's latest financial reports the company's total assets are HK$641.68 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

GlaxoSmithKline - Total assets on balance sheet (from 2001 to 2025)

Total assets by year

Year Total assets Change
2024-12-31HK$579.31 B-1.33%
2023-12-31HK$587.10 B3.27%
2022-12-31HK$568.52 B-31.72%
2021-12-31HK$832.59 B-2.04%
2020-12-31HK$849.89 B4.43%
2019-12-31HK$813.85 B41%
2018-12-31HK$577.18 B-3.05%
2017-12-31HK$595.34 B5.31%
2016-12-31HK$565.30 B-7.91%
2015-12-31HK$613.87 B25.05%
2014-12-31HK$490.90 B-8.81%
2013-12-31HK$538.31 B3.59%
2012-12-31HK$519.68 B4.79%
2011-12-31HK$495.91 B-2.25%
2010-12-31HK$507.32 B-5.66%
2009-12-31HK$537.79 B20.54%
2008-12-31HK$446.14 B-7.19%
2007-12-31HK$480.70 B23.52%
2006-12-31HK$389.15 B7.04%
2005-12-31HK$363.56 B7.64%
2004-12-31HK$337.76 B1.74%
2003-12-31HK$331.99 B18.92%
2002-12-31HK$279.17 B12.42%
2001-12-31HK$248.33 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
AstraZeneca
AZN
HK$890.67 B 38.80%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
HK$1.624 T 153.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$1.008 T 57.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$834.89 B 30.11%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
HK$1.185 T 84.72%๐Ÿ‡ซ๐Ÿ‡ท France
Teva Pharmaceutical Industries
TEVA
HK$310.15 B-51.67%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Dynavax Technologies
DVAX
HK$7.36 B-98.85%๐Ÿ‡บ๐Ÿ‡ธ USA